SEC Form 4 · accession 0001645381-15-000003
ALPINE IMMUNE SCIENCES, INC. · ALPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jun 22, 2015
Accepted (ET)
Jun 22, 2015 · 6:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626199
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2015 | C | 303,631 | $14.00 | A | 329,780 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series 2 convertible preferred stockF1 | $14.00 | Jun 22, 2015 | C | 303,631 | D | — | — | Common Stock | 303,631 | 0 | D |
Explanation of responses
- F1The Series 2 convertible preferred stock converted into common stock on a 2.889-for-1 basis and had no expiration date.